INDOCO REMEDIES
Back to Balance Sheet
|
INDOCO REMEDIES Last 5 Year Total Non-Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Assets | ₹1,429 Cr | ₹1,190 Cr | ₹845 Cr | ₹712 Cr | ₹712 Cr |
What is the latest Total Non-Current Assets ratio of INDOCO REMEDIES ?
| Year | Total Non-Current Assets |
|---|---|
| Mar2025 | ₹1,429 Cr |
| Mar2024 | ₹1,190 Cr |
| Mar2023 | ₹845 Cr |
| Mar2022 | ₹712 Cr |
| Mar2021 | ₹712 Cr |
How is Total Non-Current Assets of INDOCO REMEDIES Trending?
| Years | Total Non-Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,429 Cr | 20.04 | |
| Mar2024 | ₹1,190 Cr | 40.90 | |
| Mar2023 | ₹845 Cr | 18.55 | |
| Mar2022 | ₹712 Cr | 0.10 | |
| Mar2021 | ₹712 Cr | - | |
Compare Total Non-Current Assets of peers of INDOCO REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDOCO REMEDIES | ₹1,935.1 Cr | 5% | -0.9% | -16.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹432,096.0 Cr | -2.4% | 3% | 9.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,807.0 Cr | -3.3% | 3.5% | 4.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,718.0 Cr | -2% | 5% | 43.1% | Stock Analytics | |
| CIPLA | ₹112,971.0 Cr | -0% | 6.9% | -4.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,752.0 Cr | -0.3% | -3.8% | 7.3% | Stock Analytics | |
INDOCO REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDOCO REMEDIES | 5% |
-0.9% |
-16.2% |
| SENSEX | -0.5% |
-3.3% |
-7.6% |
You may also like the below Video Courses